We serve N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline CAS:70627-52-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline
CAS.NO: 70627-52-0
Synonyms:
Benzenamine, 4-fluoro-N-[[4-(phenylmethoxy)phenyl]methylene]-
N-(4-fluorophenyl)-1-(4-phenylmethoxyphenyl)methanimine
FR DNU1R DO1R
1-[4-(Benzyloxy)phenyl]-N-(4-fluorophenyl)methanimine
Molecular Formula: C9H5ClO2S
Molecular Weight: 212.653
Physical and Chemical Properties:
Density: 1.07 g/cm3
Boiling point: 455.2ºC at 760 mmHg
Melting point: 136-138ºC
Flash point: 229.1±25.9 °C
Refractive index: 1.558
Specification:
Appearance: Light yellow flaky crystal
Purity:≥99.0%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Ezetimibe CAS:163222-33-1.
Contact us for information like N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-[4-(Benzyloxy)phenyl]-N-(4-fluorophenyl)methanimine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenamine, 4-fluoro-N-[[4-(phenylmethoxy)phenyl]methylene]- Use and application,Benzenamine, 4-fluoro-N-[[4-(phenylmethoxy)phenyl]methylene]- technical grade,usp/ep/jp grade.
Related News: The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally.2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine manufacturer Massachusetts state health officials, in conjunction with Massport, local health departments, and other medical partners, have responded to prevent the spread of the virus.2-bromophenanthrene-9,10-dione supplier Massachusetts state health officials, in conjunction with Massport, local health departments, and other medical partners, have responded to prevent the spread of the virus.3-(2-Aminoethylamino)propyl-dimethoxymethylsilane vendor The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.
